A recent study presented at the American Heart Association's Scientific Sessions has found that spironolactone, a medication commonly known as a water pill, can significantly lower blood pressure in stroke survivors. The REDUCE trial, which involved 160 participants, showed that adding spironolactone to regular post-stroke care led to an average drop of nearly eight points in the top blood pressure number after three months. This drop is significant, as it brought the average blood pressure to about 126 from 133. Additionally, 52% of patients taking spironolactone reached the recommended blood pressure goal of less than 130/80, compared to 30% of those receiving usual post-stroke care. While the study highlights the potential benefits of spironolactone in managing blood pressure after a stroke, it also notes that more research is needed to determine if this medication can prevent subsequent strokes. Dr. Jordana Cohen, a co-lead author of the study, emphasized that lowering blood pressure is crucial in preventing another stroke, and the findings suggest that spironolactone could be a valuable addition to post-stroke care. However, caution is advised as spironolactone can cause high potassium levels and may lead to dizziness if blood pressure drops too low. Patients are encouraged to discuss with their clinicians whether this medication is suitable for their specific needs. #Spironolactone #StrokeRecovery #BloodPressure
También lo cubren: foxnews.com - Latest & Breaking News on Fox News.
Ver más en NewsToday